Medtech Portfolio Optimization: Why Investors Say No

In the medtech world, a “no” from an investor isn’t always what it seems. The decision to pass on a startup often comes down to more than just the technology—it’s a balancing act of risk, timing, and

• By lsieuropesummit,
• Published on